Alpha DNA Investment Management’s Avnet AVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-22,050
Closed -$944K 155
2022
Q2
$944K Buy
+22,050
New +$961K 0.81% 81

Other funds holding AVT

Alpha DNA Investment Management's AVT Position: Q3 2022 in Review

Alpha DNA Investment Management sold out of Avnet (AVT) in Q3 2022, closing a stake of 22,050 shares — an estimated $944K sold.

Alpha DNA Investment Management first reported a position in AVT in Q2 2022 and held it in 1 quarter. The position peaked at $944K in Q2 2022. 331 funds tracked by Wall St. Rank hold AVT as of Q3 2022.

  • Alpha DNA Investment Management reported no remaining Avnet position as of Q3 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 22,050 Avnet shares in Q3 2022, an estimated $944K.
  • Alpha DNA Investment Management first reported a position in Avnet in Q2 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's Avnet position peaked at $944K in Q2 2022.
  • 331 funds tracked by Wall St. Rank held Avnet as of Q3 2022.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.